EUVIMEDEUVIMED entdecken
Crossref

Use of Mitomycin C in Ocular Surgery; A Narrative Review

P. S. Mahar

Pakistan Journal of Ophthalmology · 2019

DOI: 10.36351/pjo.v35i3.971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Ophthalmology, 2019. Verfasst von P. S. Mahar. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitomycin C is an alkylating agent with an anti-proliferative activity. Because of its potent anti-fibroblastic effect, it is used in multiple ocular surgical procedures where inhibition of proliferation of fibroblasts and vascular ingrowths is required. It is dispensed in blue violet crystalline powder and it dissolves in water. MMC is stable for 2 weeks when refrigerated at 2 � 8 degrees centigrade after the powder is reconstituted for topical use. Because of its anti-fibroblastic activity, MMC is used in various ocular surgical procedures. The optimal dose of MMC is not known but is usually used in concentration of 0.1 mg/ml (0.01%) to 0.5 mg/ml (0.05%) in different clinical setups. Key Words: Mitomycin C, Fibroblasts, Ocular Surgery.

Zitieren

APA

Mahar, P. S. (2019). Use of Mitomycin C in Ocular Surgery; A Narrative Review. Pakistan Journal of Ophthalmology. https://doi.org/10.36351/pjo.v35i3.971

Vancouver

Mahar PS. Use of Mitomycin C in Ocular Surgery; A Narrative Review. Pakistan Journal of Ophthalmology. 2019. doi:10.36351/pjo.v35i3.971

BibTeX
@article{Mahar2019,
  author = {Mahar, P. S.},
  title = {Use of Mitomycin C in Ocular Surgery; A Narrative Review},
  journal = {Pakistan Journal of Ophthalmology},
  year = {2019},
  doi = {10.36351/pjo.v35i3.971}
}
Kostenlos starten →